Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Filaggrin is an intermediate filament-associated structural protein crucial for epidermal differentiation and formation of the skin's protective barrier. Synthesized initially as profilaggrin—a large polyprotein stored in keratohyaline granules—filaggrin is proteolytically processed into functional monomers during terminal differentiation. These monomers aggregate keratin fibers within corneocytes, flattening cells and strengthening intercellular adhesion to create an effective physical barrier against water loss and environmental insults. Subsequent degradation yields hygroscopic amino acids that constitute natural moisturizing factors essential for maintaining hydration and acidic pH on the skin surface. Mutations leading to loss or reduction of functional filaggrin disrupt these processes, resulting in conditions like atopic dermatitis (eczema), ichthyosis vulgaris, increased asthma risk due to compromised epithelial integrity, and potential autoimmune cross-reactivity. While not itself a direct drug target currently, its genetic status serves as an important biomarker for several dermatological diseases[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Filaggrin protein (FLG).